Technology & innovation

This archive covers technology and innovation breakthroughs that improve lives, protect the environment, and expand human possibility. From medical devices to clean energy tools, the stories here focus on what’s working and who’s making it happen.

Rolls-Royce & easyJet hydrogen engine, for article on hydrogen jet engine

World’s first test run of a hydrogen jet engine proves a success

By / / Good News For Humankind

Hydrogen-powered flight moved from theory to reality when Rolls-Royce and easyJet successfully ran a modern jet engine on green hydrogen produced entirely from wind and tidal energy. Unlike battery-electric approaches, hydrogen burns clean — releasing water vapor instead of carbon dioxide — and this test proved a real engine can handle it. Aviation has been one of the hardest sectors to decarbonize, so a confirmed proof of concept opens a genuine path forward. Every major breakthrough in flight history started exactly here: on the ground, with an engine, and a question that finally got answered.

Human eye up close, for article on Gennaris bionic vision system

Monash University develops world’s first bionic eye to fully restore vision in blind people

By / / Good News For Humankind

Gennaris, a bionic vision system from Monash University, could open a path to sight for people whose blindness stems from optic nerve damage — a group that most existing visual aids simply cannot help. The device bypasses the eye entirely, sending signals from a camera headset directly to tiles implanted in the brain, which then create perceivable points of light. Sheep trials confirmed the implants are safe and stable in brain tissue, and human trials are now being planned. If it succeeds, the underlying technology could eventually be adapted to assist people living with paralysis too.

Blood cells under microscope, for article on smart insulin, for article on lab-grown blood cells

First human patients receive transfusions of lab-grown blood cells

By / / Good News For Humankind

Lab-grown blood cells have reached a genuine turning point: manufactured red blood cells grown from stem cells have been safely transfused into human patients for the first time. What makes these cells special is their freshness — unlike donated blood, every lab-grown cell is the same age, meaning they should last closer to the full 120-day lifespan and reduce repeat transfusions. Early participants completed the process with no adverse effects. For millions worldwide living with blood disorders or rare blood types, this science crossing into human trials is the kind of progress that quietly changes everything.

Cancer cells, for article on radioactive implant pancreatic cancer

Radioactive implant wipes tumors in unprecedented pre-clinical success

By / / Good News For Humankind

Pancreatic cancer is one of the hardest diseases medicine has ever faced, and a new implant from Duke University is producing results that researchers say have no match in the existing scientific record. The device injects a radioactive gel directly into tumors, trapping iodine-131 so it radiates from the inside out before safely dissolving into harmless amino acids. Combined with chemotherapy, it eliminated tumors in the majority of mouse models tested. Human trials remain ahead, but for a disease where survival gains have been painfully slow, this early signal is genuinely remarkable.

Good news for public health, for article on CAB-LA HIV prevention, for article on lenacapavir HIV prevention, for article on HIV infections in young men

Zimbabwe becomes first African nation to approve HIV prevention drug

By / / Good News For Humankind

Zimbabwe just became the first country in Africa to approve cabotegravir, a long-acting HIV prevention injection given once every two months — joining only Australia and the United States. For young women and girls especially, that change is huge: a single shot replaces the daily pill regimen that stigma, privacy concerns, and patchy healthcare often make hard to sustain. It builds on a remarkable turnaround, with AIDS-related deaths in Zimbabwe falling from roughly 130,000 in 2002 to about 20,000 in 2021. As advocate Nyasha Sithole put it, ending the epidemic requires a real “basket of tools.” Zimbabwe’s quick action sends a powerful signal that African regulators don’t have to wait in line for life-saving HIV breakthroughs.